Navigation Links
Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
Date:4/17/2008

PALO ALTO, Calif., April 17 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK), a biopharmaceutical company focused on discovering and developing drugs to treat serious diseases, today announced that it made four preclinical data presentations at the 99th Annual Meeting of the American Association for Cancer Research (AACR) in San Diego, Calif. The abstracts highlighted results from Telik's Research and Development programs.

Identification and Characterization of Novel Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor 2 [Abstract # 1439]

Inhibition of the vascular endothelial growth factor receptor signaling

pathway with antibodies or small molecules has been proven effective as an

anti-cancer therapy. Through the use of Telik's Target-Related Affinity

Profiling (TRAP(R)) screening technology, novel inhibitors of VEGFR2

kinase were discovered. The inhibitors belong to nine structural classes,

among which E2B8 and EAAF are sub-micromolar inhibitors of the kinase.

Mechanism of Induction of Apoptosis by TLK199 (TELINTRA(R)) in Human Leukemia Cell Lines [Abstract # 2270]

Telik researchers conducted studies with data highlighting TLK199, a novel

glutathione analog inhibitor of the enzyme glutathione S-transferase P1-1,

which induces apoptosis, or programmed cell death, in human HL60

promyelocytic cells and TF-1 erythroleukemic cells. Treatment of the

leukemia cells with TLK199 also resulted in an increase of the

phosphorylation of eIF2alpha, a key signaling event in the integrated

stress response (ISR), and in induction of multiple genes implicated in

ISR. Telik currently has ongoing studies of T
'/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance
2. Telik Announces Revised Date for Year-End Financial Release, Conference Call and Webcast
3. Telik Announces Year-End Financial Release, Conference Call and Webcast
4. Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
5. Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
6. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
7. ProMetic presents preclinical data for prostate and pancreatic cancer at the AACR Meeting
8. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
9. Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR
10. Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040
11. SGX Presents Preclinical MET Data at AACR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Swecure, ein Biotechnologieunternehmen, ... Entwicklung neuartiger Therapien für Störungen des Immunsystems ... konzentriert, erhält vom US Patent and Trademark ... patentiert wird. Das Medikament basiert auf einem ... und Entzündungen vorbeugt.   Das Medikament, ...
(Date:9/1/2015)... The American Brain Tumor Association (ABTA) is ... Research Grant program. LOIs are due no later than ... Discovery Grants are one-year, $50,000 grants that fund ... current diagnostic or treatment paradigms for adults and children ... at its earliest stages, in the hopes that it ...
(Date:9/1/2015)... , Sept. 1, 2015 Prostate ... death in American men. One in seven ... 233,000 new cases are diagnosed annually. That said, ... using a powerful new technique, MRI Fusion Biopsy, ... large cancer lesions, treating only the affected areas ...
(Date:9/1/2015)... ... September 01, 2015 , ... In her thought provoking debut novel ‘ Ebola ... not-so-distant future faced with an Ebola pandemic that is on the cusp of wiping ... enter the world of counterterrorism, and who continues to appear in this series of ...
Breaking Biology Technology:Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2American Brain Tumor Association Seeks Innovative Concepts For Discovery Research Grants 2September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3
... During July 2003, two British education officals visited ... be exported. At a time when many Wisconsin ... other cities and regions, it is ironic that ... the same challenges and have turned to Wisconsin ...
... regulatory approvals for the $2.3 billion acquisition of Instrumentarium ... of two divisions of the company they are acquiring. ... plans to integrate Instrumentarium it into its GE ... Dow Wilson.. , ,The final required regulatory ...
... open a new state-of-art healthcare facility in October, 2003. ... in digital imaging technology from technology vendor Emageon. Both ... distribution of digital medical images across its integrated delivery ... 1984 is a nationally recognized leader in efforts to ...
Cached Biology Technology:Aurora Selects New Imaging Technology 2
(Date:8/6/2015)... and TELTOW, Germany , ... 2015 Siggraph Conference, SensoMotoric Instruments (SMI) shows ... reality , based on Epson,s Moverio BT-200 ... tracking platform. With this new solution, unprecedented quality and ... hands-free interaction with context-sensitive displays. For the first time, ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors ... growth in applications, penetration into newer sectors, and development ... The global biosensors space has seen the entry of ... market so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ... Sullivan, Analysis of the Global Biosensors Market ...
(Date:7/31/2015)... 31. juli 2015 Den 10. internationale konference ... BGI fra den 22. - 25. oktober i ... sin 10-års fødselsdag i år. Siden starten i 2006 ... møder på ,omik,-feltet, og er en af de mest ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden for ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... a common occurrence that appears over heavily forested areas around ... human activities can worsen it to the point of affecting ... to a study led by a Texas A&M University researcher. ... air chemistry for more than 20 years, says blue haze ...
... Penn., Oct. 5, 2009 Completing a major milestone in ... announced that it has sourced readers for 150 clinical trials. ... Imaging for a leading pharmaceutical company, was designed to test ... The trial used medical imaging to support the primary analysis ...
... Science Picks via e-mail, would like to change the recipient ... kcapelli@usgs.gov . October Highlights: Responding ... Climate Change, Water is Out of This World, Gender Line ... Necklace! Learn More about Bats and Rabies, Winter Warming Affects ...
Cached Biology News:Going green on hold: Man-made activities can affect 'blue haze,' world's weather 2RadMD reaches 150th clinical trial 2USGS Science Picks 2USGS Science Picks 3USGS Science Picks 4USGS Science Picks 5USGS Science Picks 6USGS Science Picks 7USGS Science Picks 8USGS Science Picks 9
... sets a new standard for high performance ... new design in instrumentation, this easy-to-use benchtop ... The BD FACSAria instrument is the first ... flow cell. This new flow cell ...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
Biology Products: